You are here: All Products  > Biosyngen Approved for US Trials of TCR-T Candidate for Solid Tumor Cancers

Biosyngen Approved for US Trials of TCR-T Candidate for Solid Tumor Cancers

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products